The lack of systemic and subclinical side effects of botulinum neurotoxin type-a in patients affected by post-stroke spasticity: a longitudinal cohort study

HIGHLIGHTS

  • who: Marco Battaglia and collaborators from the , Novara, Italy Physical and Rehabilitation Medicine, "Ospedale Maggiore della Carità" University Hospital have published the research work: The Lack of Systemic and Subclinical Side Effects of Botulinum Neurotoxin Type-A in Patients Affected by Post-Stroke Spasticity: A Longitudinal Cohort Study, in the Journal: (JOURNAL) of 28/06/2021
  • what: Throughout the inclusion of subjects treated with lower doses of BoNT-A and considering the three main formulations (Incobotulinumtoxin A, Abobotulinumtoxin A, and Onabotulinumtoxin A), this study aims to investigate an additional population with a larger sample size . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?